Donald Wolanin

Donald J. Wolanin, Ph.D., is an accomplished educator and research professional, blending a distinguished academic journey with a substantial pharmaceutical background. He holds M.A. and Ph.D. degrees in Chemistry from Harvard University in addition to a B.S. in Chemistry from the University of Chicago. Dr. Wolanin's early career featured roles as Head Teaching Fellow at Harvard and several research positions at ICI Pharmaceuticals Group (now Astra-Zeneca). At Bayer Corporation, he progressed from Senior Staff Scientist to Director of Research, showcasing expertise in research management and strategic program support. His contributions span preclinical development in diverse therapeutic areas, including cancer, arthritis, and diabetes. Transitioning to academia, he became an Adjunct Faculty Member at several institutions, teaching Chemistry with a focus on practical applications. Committed to education, he consistently exhibits a passion for fostering learning environments and advancing scientific progress.